<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04742231</url>
  </required_header>
  <id_info>
    <org_study_id>20-004730</org_study_id>
    <nct_id>NCT04742231</nct_id>
  </id_info>
  <brief_title>Handheld Dynamometer During Awake Craniotomy Pilot</brief_title>
  <official_title>Use of Handheld Dynamometer as a Novel Tool to Assess Motor Function During Awake Craniotomy for Brain Lesions Located Within or Adjacent to the Motor Cortex: A Single-Center Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to assess the feasibility, safety and reliability of the&#xD;
      use of handheld dynamometry in evaluating intraoperative motor function for patients&#xD;
      undergoing awake craniotomy for the resection of brain lesions located within or adjacent to&#xD;
      the motor cortex.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative maximum grip strength (KgF) baseline</measure>
    <time_frame>1 day</time_frame>
    <description>Maximum grip strength (KgF) will be measured using hand-held dynamometry every 2 minutes from the time the patient awakes until the end of surgery. Intraoperative maximum grip strength baseline is defined as the mean of 3 consecutive measures with &lt;10% variability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraoperative maximum grip strength (KgF) variability</measure>
    <time_frame>1 day</time_frame>
    <description>To validate the use of hand-held dynamometry as an adequate tool to monitor intraoperative motor function during awake craniotomies (AC), maximum grip strength (KgF) will be measured every 2 minutes from the time the patient awakes to the end of surgery. The intra-individual variability will be defined as the percent difference between sets with 10% or greater defined as substantial variability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum grip strength (KgF) variability from preoperative baseline</measure>
    <time_frame>1 day</time_frame>
    <description>To validate the use of hand-held dynamometry as an adequate tool to monitor intraoperative motor function during AC, each patient will be baselined (mean of 6 consecutive measurements) during the preoperative neuropsychology evaluation. Variability from preoperative baseline will be calculated as a percentile [ (Preoperative Baseline/ Intraoperative Baseline)/ Preoperative Baseline) * 100]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Operative Time (Minutes)</measure>
    <time_frame>1 day</time_frame>
    <description>Defined as the duration of the procedure from the initiation of skin incision to the completion of skin closure according to anesthesia records. Measured in minutes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation Coefficient (ρ) between hand-held dynamometry and manual motor testing during AC</measure>
    <time_frame>1 day</time_frame>
    <description>Concordance between hand-held dynamometer and manual motor testing will be evaluated using Spearmans' correlation coefficient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Maximum Grip Strength (KgF)</measure>
    <time_frame>1 month</time_frame>
    <description>Postoperative Maximum Grip strength (KgF) will be measured using hand-held dynamometer at day 1 and at 1 month follow-up.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Brain Lesion</condition>
  <condition>Brain Tumor Adult</condition>
  <condition>Brain Tumor</condition>
  <arm_group>
    <arm_group_label>Cohort 1. Patients with brain lesions in non-motor areas undergoing an awake craniotomy (AC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 patient minimum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2. Patients with brain lesions within or proximal to motor areas undergoing an AC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 patient minimum</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hand-held dynamometer</intervention_name>
    <description>Maximum Grip Strength will be measured using a hand-held dynamometer (K-FORCE Grip dynamometer®. Kinvent Biomequanique S.A.S, Montpellier, France) during the preoperative, intraoperative (Awake craniotomy) and postoperative period.</description>
    <arm_group_label>Cohort 1. Patients with brain lesions in non-motor areas undergoing an awake craniotomy (AC)</arm_group_label>
    <arm_group_label>Cohort 2. Patients with brain lesions within or proximal to motor areas undergoing an AC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients ≥ 18 years old.&#xD;
&#xD;
          -  Primary or Recurrent Brain tumors&#xD;
&#xD;
          -  Single brain lesion&#xD;
&#xD;
          -  Lesion within or adjacent to the motor cortex- Lesion located within the primary or&#xD;
             supplementary motor area (Verified by preoperative fMRI and DTI).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients &lt; 18 years old.&#xD;
&#xD;
          -  Major comorbidities (congestive heart failure, severe chronic obstructive pulmonary&#xD;
             disease, morbid obesity, obstructive sleep apnea).&#xD;
&#xD;
          -  Patients with cognitive, intellectual or psychiatric impairment that could affect the&#xD;
             capacity of following instructions evaluated during preoperative neuropsychological&#xD;
             testing.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaisorn Chaichana, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaisorn L Chaichana, M.D.</last_name>
      <phone>410-262-7828</phone>
      <email>Chaichana.Kaisorn@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Lina C Marenco-Hillembrand, M.D.</last_name>
      <phone>9044228162</phone>
      <email>marenco.lina@mayo.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 16, 2020</study_first_submitted>
  <study_first_submitted_qc>February 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Kaisorn L. Chaichana</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Awake Craniotomy</keyword>
  <keyword>Dynamometer</keyword>
  <keyword>Motor</keyword>
  <keyword>Brain Mapping</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

